Clinical Trials on Estrogen Supplementation in Spain
Total 18 results
-
Universidad Católica San Antonio de MurciaCompleted
-
Universidad Católica San Antonio de MurciaCompletedSupplementation | CyclistsSpain
-
Universidad Católica San Antonio de MurciaCompletedBeta Alanine SupplementationSpain
-
Universidad Católica San Antonio de MurciaCompletedBeta Alanine SupplementationSpain
-
Universidad Católica San Antonio de MurciaCompletedBeta Alanine SupplementationSpain
-
Universidad Católica San Antonio de MurciaCompletedBack Pain | SupplementationSpain
-
Universidad Católica San Antonio de MurciaCompletedObesity | SupplementationSpain
-
University of CadizCompletedPlacebo | Cold-water Immersion | Protein-carbohydrates Supplementation | Active RecoverySpain
-
University of DeustoPoznan University of Medical Sciences; Hospital de Basurto; Hospital de Cruces; Hospital Universitario de Burgos and other collaboratorsRecruitingQuality of Life | Breast Cancer | Supplementation | Resistance Training | Physical PerformanceSpain
-
University of ValenciaCompletedAtherosclerosis | Menopause | Women | Estrogens | Carotid Intima-media Thickness | Coronary StenosesSpain
-
UNICANCERBreast International GroupCompletedBreast Cancer | Menopause | Estrogen Receptor Positive Tumor | Hormone AntagonistFrance, Sweden, Spain
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France